IL-6 enhances the cytotoxic activity of thymocyte-derived CD56+ cells.

[1]  S. Iho,et al.  Characteristics of interleukin-6-enhanced lymphokine-activated killer cell function. , 1991, Cellular immunology.

[2]  M. Smyth,et al.  Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes. , 1991, Journal of immunology.

[3]  R. Biassoni,et al.  In vitro expansion of CD3/TCR- human thymocyte populations that selectively lack CD3 delta gene expression: a phenotypic and functional analysis , 1990, The Journal of experimental medicine.

[4]  H. Young,et al.  IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. , 1990, Journal of immunology.

[5]  T. Luger,et al.  IFN-beta 2/IL-6 augments the activity of human natural killer cells. , 1989, Journal of immunology.

[6]  T. Hirano,et al.  IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. , 1988, Journal of immunology.

[7]  F. Ramsdell,et al.  Similarities between LAK cells derived from human thymocytes and peripheral blood lymphocytes: expression of the NKH-1 and CD3 antigens. , 1988, Cellular immunology.

[8]  J. Gray,et al.  Lymphocytes expressing type 3 complement receptors proliferate in response to interleukin 2 and are the precursors of lymphokine-activated killer cells. , 1988, The Journal of clinical investigation.

[9]  S. Clark,et al.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. , 1988, Journal of immunology.

[10]  F. Ramsdell,et al.  Generation of lymphokine-activated killer cell activity from human thymocytes. , 1987, Journal of immunology.

[11]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[12]  J. Ortaldo,et al.  Lymphokine-activated killer cells. Analysis of progenitors and effectors , 1986, The Journal of experimental medicine.

[13]  L. Lanier,et al.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis , 1986, The Journal of experimental medicine.

[14]  S. Golub,et al.  Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells. , 1985, Journal of immunology.

[15]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.